Talk:Tocilizumab

Pharmacology High‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
High	This article has been rated as High-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

COVID-19 High‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
High	This article has been rated as High-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tocilizumab.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Untitled

Removed link to tocilizumab.com, which seems to be purely a collection of sponsored links, and not an official site. 81.107.41.207 (talk) 12:30, 21 March 2008 (UTC) Tocilizumab is great for halting arthritis. http://news.bbc.co.uk/2/hi/health/7692701.stm reports 47% of patients tested saw improvement over only 8% when methotrexate was taken alone. Karpinski (talk) 15:16, 27 October 2008 (UTC) —Preceding unsigned comment added by Karpinski (talk • contribs) 15:14, 27 October 2008 (UTC)[reply]

Five trials

The LITHE trial was reported extensively, but there have been several other phase III trials. http://arthritis.about.com/od/brms/a/actemra.htm sums them up. JFW | T@lk 10:25, 31 October 2008 (UTC)[reply]

"at 11 locations in China"

Is not really needed. It is in the reference. Doc James (talk · contribs · email) 23:11, 9 April 2020 (UTC)[reply]

Text

"This ability to counter cytokine release syndrome, also known as a cytokine storm, enables the use of Tocilizumab to treat the most extreme cases of COVID-19.^[1]"

We need a proper reference. No we do not have evidence that this treats the most extreme cases... Doc James (talk · contribs · email) 02:53, 15 April 2020 (UTC)[reply]

References

^ Buchele, Mose (13 April 2020). "'I Felt Like Rip Van Winkle': One Of The 1st U.S. Doctors With COVID-19 Is Back Home". NPR. NPR. Retrieved 15 April 2020.

[1] Buchele, Mose (13 April 2020). "'I Felt Like Rip Van Winkle': One Of The 1st U.S. Doctors With COVID-19 Is Back Home". NPR. NPR. Retrieved 15 April 2020.

[1]

Talk:Tocilizumab

Untitled

Five trials

"at 11 locations in China"

Text

Navigation menu

Search